Merck & Company, Inc.Merck & Company, Inc.Merck & Company, Inc.

Merck & Company, Inc.

No trades
See on Supercharts
Market capitalization
‪319.59 B‬USD
‪365.00 M‬USD
‪59.87 B‬USD
‪2.53 B‬
Beta (1Y)
0.10

About Merck & Company, Inc.

CEO
Robert M. Davis
Headquarters
Rahway
Website
Employees (FY)
‪72 K‬
Founded
1891
ISIN
US58933Y1055
FIGI
BBG000BPD168
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MRK is 126.19 USD — it has increased by 0.36% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Merck & Company, Inc. stocks are traded under the ticker MRK.
Merck & Company, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Merck & Company, Inc. has a max estimate of 148.00 USD and a min estimate of 118.00 USD.
MRK earnings for the last quarter are 2.13 USD whereas the estimation was 1.95 USD which accounts for 9.04% surprise. Estimated earnings for the next quarter are −0.11 USD. See more details about Merck & Company, Inc. earnings.
Merck & Company, Inc. revenue for the last quarter amounts to ‪15.96 B‬ USD despite the estimated figure of ‪15.30 B‬ USD. In the next quarter revenue is expected to reach ‪14.49 B‬ USD.
Yes, you can track Merck & Company, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, MRK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merck & Company, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MRK reached its all-time high on Mar 27, 2024 with the price of 133.10 USD, and its all-time low was 0.97 USD and was reached on Aug 13, 1970.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪72.00 K‬ employees. See our rating of the largest employees — is Merck & Company, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Merck & Company, Inc. EBITDA is ‪6.92 B‬ USD, and current EBITDA margin is 11.45%. See more stats in Merck & Company, Inc. financial statements.